Related references
Note: Only part of the references are listed.Maternal Use of Hydroxychloroquine Is Associated With a Reduced Risk of Recurrent Anti-SSA/Ro-Antibody-Associated Cardiac Manifestations of Neonatal Lupus
Peter M. Izmirly et al.
CIRCULATION (2012)
Comparison of different screening methods for chloroquine/hydroxychloroquine retinopathy: multifocal electroretinography, color vision, perimetry, ophthalmoscopy, and fluorescein angiography
Susann Missner et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2012)
Targeted therapies in systemic lupus erythematosus: successes, failures and future
Bevra H. Hahn
ANNALS OF THE RHEUMATIC DISEASES (2011)
Retinal Toxicity Associated With Hydroxychloroquine and Chloroquine Risk Factors, Screening, and Progression Despite Cessation of Therapy
Michel Michaelides et al.
ARCHIVES OF OPHTHALMOLOGY (2011)
Re-evaluation of antimalarials in treating rheumatic diseases: re-appreciation and insights into new mechanisms of action
Steven J. Katz et al.
CURRENT OPINION IN RHEUMATOLOGY (2011)
Humphrey visual field findings in hydroxychloroquine toxicity
C. Anderson et al.
EYE (2011)
Hypoglycemia Induced by Hydroxychloroquine in a Patient Treated for Rheumatoid Arthritis
Mustafa Unubol et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2011)
Mechanism of Endosomal TLR Inhibition by Antimalarial Drugs and Imidazoquinolines
Alenka Kuznik et al.
JOURNAL OF IMMUNOLOGY (2011)
Ocular Toxicity in Children Exposed in Utero to Antimalarial Drugs: Review of the Literature
Alla Osadchy et al.
JOURNAL OF RHEUMATOLOGY (2011)
Revised Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy
Michael F. Marmor et al.
OPHTHALMOLOGY (2011)
Importance of cumulative exposure to elevated cholesterol and blood pressure in development of atherosclerotic coronary artery disease in systemic lupus erythematosus: a prospective proof-of-concept cohort study
Mandana Nikpour et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review
G. Ruiz-Irastorza et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Antimalarial Treatment May Have a Time-Dependent Effect on Lupus Survival
Samuel K. Shinjo et al.
ARTHRITIS AND RHEUMATISM (2010)
The Protective Effect of Antimalarial Drugs on Thrombovascular Events in Systemic Lupus Erythematosus
Hyejung Jung et al.
ARTHRITIS AND RHEUMATISM (2010)
Effect of Medication on Microvascular Vasodilatation in Patients with Systemic Lupus Erythematosus
Christine Bengtsson et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2010)
Hydroxychloroquine and Glycemia in Women with Rheumatoid Arthritis and Systemic Lupus Erythematosus
Sara Kaprove Penn et al.
JOURNAL OF RHEUMATOLOGY (2010)
Rates and Predictors of Hydroxychloroquine Retinal Toxicity in Patients With Rheumatoid Arthritis and Systemic Lupus Erythematosus
Frederick Wolfe et al.
ARTHRITIS CARE & RESEARCH (2010)
Systemic Lupus Erythematosus and the Risk of Cardiovascular Disease: Results From the Nurses' Health Study
A. Elisabeth Hak et al.
ARTHRITIS CARE & RESEARCH (2009)
Frequency and Determinants of Flare and Persistently Active Disease in Systemic Lupus Erythematosus
Mandana Nikpour et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
Protective Effect of Hydroxychloroquine on Renal Damage in Patients With Lupus Nephritis: LXV, Data From a Multiethnic US Cohort
Guillermo J. Pons-Estel et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
Spectral domain optical coherence tomography detects early stages of chloroquine retinopathy similar to multifocal electroretinography, fundus autofluorescence and near-infrared autofluorescence
S. Kellner et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2009)
The potential negative impact of proton pump inhibitors on the immunopharmacologic effects of chloroquine and hydroxychloroquine
M. R. Namazi
LUPUS (2009)
Epidemiology of atherosclerosis in systemic lupus erythematosus
Mandana Nikpour et al.
Current Rheumatology Reports (2009)
Comparative study of efficacy and safety of hydroxychloroquine and chloroquine in polymorphic light eruption: A randomized, double-blind, multicentric study
Anil Pareek et al.
INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY (2008)
Ocular Toxicity of Hydroxychloroquine
Rodney Tehrani et al.
Seminars in Ophthalmology (2008)
Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus:: Data from LUMINA, a multiethnic US cohort (LUMINA L)
Graciela S. Alarcon et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Therapy Insight: the use of antirheumatic drugs during nursing
Monika Ostensen et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2007)
New concepts in antimalarial use and mode of action in dermatology
Sunil Kalia et al.
DERMATOLOGIC THERAPY (2007)
Antimalarials may influence the risk of malignancy in systemic lupus erythematosus
G. Ruiz-Irastorza et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Detection of early hydroxychloroquine retinal toxicity enhanced by ring ratio analysis of multifocal electroretinography
Jonathan S. Lyons et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2007)
Heart conduction disorders related to antimalarials toxicity: an analysis of electrocardiograms in 85 patients treated with hydroxychloroquine for connective tissue diseases
N. Costedoat-Chalumeau et al.
RHEUMATOLOGY (2007)
Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosus
J. A. James et al.
LUPUS (2007)
Cardiomyopathy related to antimalarial therapy with illustrative case report
Nathalie Costedoat-Chalumeau et al.
CARDIOLOGY (2007)
Hydroxychloroquine in lupus pregnancy
Megan E. B. Clowse et al.
ARTHRITIS AND RHEUMATISM (2006)
Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus
Nathalie Costedoat-Chalumeau et al.
ARTHRITIS AND RHEUMATISM (2006)
Chronic hydroxychloroquine use associated with QT prolongation and refractory ventricular arrhythmia
CY Chen et al.
CLINICAL TOXICOLOGY (2006)
Chloroquine treatment influences proinflammatory cytokine levels in systemic lupus erythematosus patients
A Wozniacka et al.
LUPUS (2006)
Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus
G. Ruiz-Irastorza et al.
LUPUS (2006)
Hydroxychloroquine use predicts complete renal remission within 12 months among patients treated with mycophenolate mofetil therapy for membranous lupus nephritis
N. Kasitanon et al.
LUPUS (2006)
Anti-inflammatory and immunosuppressive drugs and reproduction
Monika Ostensen et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Cytokine polymorphisms influence treatment outcomes in SLE patients treated with antimalarial drugs
Patricia Lopez et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Multifocal electroretinographic changes in patients receiving hydroxychloroquine therapy
TYY Lai et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2005)
Systemic lupus erythematosus in a multiethnic cohort (LUMINA):: XXVIII.: Factors predictive of thrombotic events
KT Ho et al.
RHEUMATOLOGY (2005)
Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature
N Costedoat-Chalumeau et al.
AUTOIMMUNITY REVIEWS (2005)
Pharmacogenetics of disease-modifying anti-rheumatic drugs
E Tanaka et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2004)
Safety of hydroxychloroquine in pregnant patients with connective tissue diseases - A study of one hundred thirty-three cases compared with a control group
N Costedoat-Chalumeau et al.
ARTHRITIS AND RHEUMATISM (2003)
The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine - A reappraisal
I Mavrikakis et al.
OPHTHALMOLOGY (2003)
New American Academy of Ophthalmology recommendations on screening for hydroxychloroquine retinopathy
MF Marmor
ARTHRITIS AND RHEUMATISM (2003)
Recommendations on screening for chloroquine and hydroxychloroquine retinopathy - A report by the American Academy of Ophthalmology
MF Marmor et al.
OPHTHALMOLOGY (2002)
Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus:: a prospective study of 103 pregnancies
J Cortés-Hernández et al.
RHEUMATOLOGY (2002)
The effectiveness of hydroxychloroquine in patients with type 2 diabetes mellitus who are refractory to sulfonylureas - a randomized trial
HC Gerstein et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2002)
Vascular stiffness in women with systemic lupus erythematosus
F Selzer et al.
HYPERTENSION (2001)
Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study
RA Levy et al.
LUPUS (2001)
Chloroquine interferes with lipopolysaccharide-induced TNF-α gene expression by a nonlysosomotropic mechanism
SM Weber et al.
JOURNAL OF IMMUNOLOGY (2000)
Oral mucosal hyperpigmentation secondary to antimalarial drug therapy
CL Kleinegger et al.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY (2000)
Influence of hydroxychloroquine on the bioavailability of oral metoprolol
M Somer et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2000)
Share Paper
